Stay updated on BA3071 in PD-1 Combo for Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the BA3071 in PD-1 Combo for Solid Tumors Clinical Trial page.
Latest updates to the BA3071 in PD-1 Combo for Solid Tumors Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check14 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information on who can answer questions about joining the study and where it is taking place, with a reference to the Contacts and Locations section.SummaryDifference3%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has added new features for user interaction while removing detailed options for participant groups, interventions, and various data fields related to studies.SummaryDifference5%
- Check36 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference5%
- Check50 days agoChange DetectedNew additions include an experimental neoadjuvant combination therapy involving a conditionally active biologic antibody targeting CTLA-4 and PD-1, along with chemotherapy options, while the previous version v2.12.0 has been removed.SummaryDifference4%
- Check58 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.2%
Stay in the know with updates to BA3071 in PD-1 Combo for Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BA3071 in PD-1 Combo for Solid Tumors Clinical Trial page.